These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3182964)

  • 21. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum metabolism and bone histology after kidney transplantation: a one-year follow-up study.
    Nordal KP; Dahl E; Halse J; Aksnes L; Thomassen Y; Flatmark A
    J Clin Endocrinol Metab; 1992 May; 74(5):1140-5. PubMed ID: 1569161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
    ASAIO J; 1992; 38(3):M593-5. PubMed ID: 1457929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.
    Malberti F; Surian M; Cosci P
    Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Pasquali M; Perruzza I; Manni M; Sardella D
    Miner Electrolyte Metab; 1991; 17(3):153-9. PubMed ID: 1779936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is skeletal response to parathyroid hormone abnormal in experimental renal failure?
    Patel S; Hsu CH
    J Lab Clin Med; 1988 Sep; 112(3):387-93. PubMed ID: 3411200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
    Wadhwa NK; Suh H; Howell N; Cabralda T; Sokunbi D; Solomon M
    Adv Perit Dial; 1993; 9():260-3. PubMed ID: 8105939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled trial of calcitriol in hemodialysis patients.
    Baker LR; Muir JW; Sharman VL; Abrams SM; Greenwood RN; Cattell WR; Goodwin FJ; Marsh FP; Adami S; Hately W
    Clin Nephrol; 1986 Oct; 26(4):185-91. PubMed ID: 3536232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators.
    Chan JC; McEnery PT; Chinchilli VM; Abitbol CL; Boineau FG; Friedman AL; Lum GM; Roy S; Ruley EJ; Strife CF
    J Pediatr; 1994 Apr; 124(4):520-8. PubMed ID: 8151464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal osteodystrophy in predialysis patients without stainable bone aluminum. A cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Attramadal A; Halse J; Flatmark A
    Acta Med Scand; 1988; 224(2):157-64. PubMed ID: 2458677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.
    Malluche HH; Faugere MC; Friedler RM; Matthews C; Fanti P
    J Clin Invest; 1987 Mar; 79(3):754-61. PubMed ID: 3818947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Donato G; Massimetti C; Ballanti P; Bondatti F; Della Rocca C; Smacchi A; Mantazzoli F; Cinotti GA
    Adv Exp Med Biol; 1986; 208():297-303. PubMed ID: 3494388
    [No Abstract]   [Full Text] [Related]  

  • 36. Calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
    Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.
    Ott SM; Maloney NA; Coburn JW; Alfrey AC; Sherrard DJ
    N Engl J Med; 1982 Sep; 307(12):709-13. PubMed ID: 6896740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with 1,25(QH)2D3 in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Costantini S; Bonucci E; Bondatti F; Manni M; Pasquali M; Sardella D; Taggi F
    Contrib Nephrol; 1991; 90():183-8. PubMed ID: 1959344
    [No Abstract]   [Full Text] [Related]  

  • 39. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.
    Baker LR; Abrams L; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int; 1989 Feb; 35(2):661-9. PubMed ID: 2651758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of long-term treatment of predialysis renal bone disease with 1-alpha-hydroxy-derivatives of vitamin D.
    Juttmann JR; Birkenhäger-Frenkel DH; Visser TJ; van Krimpen C; Birkenhäger JC
    J Steroid Biochem; 1983 Jul; 19(1B):511-6. PubMed ID: 6688450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.